References:
1. Salvarani C, Crowson CS, O’Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum.2004;51(2):264-268.
2. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years.Arthritis Rheum. 2003;48(12):3522-3531.
3. Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J.2014;35(41):2873-2926.
4. Gornik HL, Creager MA. Aortitis. Circulation.2008;117(23):3039-3051.
5. Kebed DT, Bois JP, Connolly HM, et al. Spectrum of Aortic Disease in the Giant Cell Arteritis Population. Am J Cardiol.2018;121(4):501-508.
6. Kermani TA, Warrington KJ, Crowson CS, et al. Predictors of Dissection in Aortic Aneurysms From Giant Cell Arteritis. J Clin Rheumatol. 2016;22(4):184-187.
7. Zehr KJ, Mathur A, Orszulak TA, Mullany CJ, Schaff HV. Surgical treatment of ascending aortic aneurysms in patients with giant cell aortitis. Ann Thorac Surg. 2005;79(5):1512-1517.